4//SEC Filing
Schneider Eugene 4
Accession 0000874015-25-000211
CIK 0000874015other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 8:28 PM ET
Size
10.7 KB
Accession
0000874015-25-000211
Insider Transaction Report
Form 4
Schneider Eugene
EVP, Chf Clinical Develop Ofcr
Transactions
- Exercise/Conversion
Common Stock
2025-09-03$53.77/sh+19,658$1,057,011→ 71,165 total - Sale
Common Stock
2025-09-03$61.42/sh−7,203$442,382→ 51,507 total - Sale
Common Stock
2025-09-03$60.46/sh−12,455$753,039→ 58,710 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-09-03−19,658→ 0 totalExercise: $53.77From: 2020-01-02Exp: 2026-01-01→ Common Stock (19,658 underlying)
Footnotes (3)
- [F1]Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 2, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.1862 to $61.14 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc., any security holder of Ionis Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.21 to $61.66 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc., any security holder of Ionis Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0001838539
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 8:28 PM ET
- Size
- 10.7 KB